Convalife Pharmaceuticals

Shanghai, China · Founded 2015 · In IPO Registration

Researcher and developer of innovative drugs focused on oncology treatments. Convalife Pharmaceuticals is based in Shanghai, China and was founded in 2015. Its last reported valuation was $445 million in Jul 2025. It has raised $59.8 million.

Last reported valuation
$444.6M
Oct 2026
Priced at
—
Total raised
$59.8M
Last round
—

Who backs Convalife Pharmaceuticals?

12 investors
InvestorType
Optics Valley Financial Holdings GroupOther
Fujian Shangrun Investment ManagementOther
Beijing Chuangye Letu Technology Group—
Chengrong Investment—
Hiway Capital—
Jointown Investment—
Realharmony Capital—
Veken Holding Group—
Vista Investment—
WuXi Biologics—
+ 2 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Convalife Pharmaceuticals investors

12 investors are on record for Convalife Pharmaceuticals, including Optics Valley Financial Holdings Group, Fujian Shangrun Investment Management, Beijing Chuangye Letu Technology Group and Chengrong Investment.

Free account
More of Convalife Pharmaceuticals with a free account
  • ·The complete investor list: 12 names
  • ·Watch Convalife Pharmaceuticals: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 12 firms already write checks for companies like Convalife Pharmaceuticals. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View